First-Ever
Peer-Reviewed Study of Vaccinated vs Unvaccinated Children Shows Vaccinated
Kids Have a Higher Rate of Sickness, 470% Increase in Autism
May 7, 2017 Mark Blaxill, Age of Autism Health 9
Pilot Comparative
Study on the Health of Vaccinated and Unvaccinated 6-12 Year Old US Children
In a development that autism parents have long
anticipated, the first-ever, peer-reviewed study comparing total health
outcomes in vaccinated and unvaccinated children was released on line
yesterday. According to sources close to the project, the study had been
reviewed and accepted by two different journals, both of which pulled back on
their approval once the political implications of the findings became clear.
That’s largely because, as parents have long expected, the rate of autism is
significantly higher in the vaccinated group, a finding that could shake
vaccine safety claims just as the first president who has ever stated a belief
in a link between vaccines and autism has taken office.
Working in partnership with the National Home Education
Research Institute (NHERI), Dr. Anthony Mawson led a research team that
investigated the relationship between vaccination exposures and a range of over
40 acute and chronic illnesses in home schooled children, a population chosen
for its high proportion of unvaccinated children. Surveying families in four
states–Florida, Louisiana, Mississippi and Oregon—the study (officially titled Vaccination
and Health Outcomes: A Survey of 6- to 12-year-old Vaccinated and Unvaccinated
Children based on Mothers’ Reports), reported a number of startling
findings.
Vaccinated children were significantly more likely than
the unvaccinated to have been diagnosed with a neurodevelopmental disorder:
most notably, the risk of being affected by an Autism Spectrum Disorder (ASD)
was 4.7 fold higher in vaccinated children; as well, ADHD risk was 4.7 fold
higher and learning disability risk was 3.7 fold higher. Overall, the
vaccinated children in the study were 3.7 times more likely to have been
diagnosed with some kind of neurodevelopmental disorder.
Vaccinated children were also significantly more likely
to be diagnosed with an immune-related disorder. The risk of allergic rhinitis
(commonly known as hay fever) was over 30 times higher in vaccinated children,
while the risk of other allergies was increased 3.9 fold and the eczema risk
was increased 2.4 fold.
With respect to acute illness and infectious disease the
outcomes were in some respects surprising. As might be expected,
unvaccinated children were significantly (4-10 times) more likely to have come
down with chicken pox, rubella or pertussis. Perhaps unexpectedly, the
unvaccinated children were less likely to suffer from otitis media and
pneumonia: vaccinated children had 3.8 times greater odds of a middle ear
infection and 5.9 times greater odds of a bout with pneumonia.
The study was based on a survey with participants
recruited in a process led by NHERI and coordinated through 84 state and local
homeschool groups. The survey itself was, according to the authors, “nonbiased
and neutrally worded.”
These findings in a study population of 666 children, 261
of whom (39%) were unvaccinated, are sure to stir controversy, in part because
it is the first of its kind. The scientific literature on the long-term effects
of the vaccination program is virtually silent. Most studies on the safety of
vaccines only consider immediate or short-term effects. There was no obvious
explanation for the differences in health outcomes observed between the
vaccinated and unvaccinated groups of children other than vaccination itself.
The finding that vaccination is a significant risk for
autism is the most explosive finding in the paper. For well over a decade,
parents concerned that vaccines were involved in autism’s sharp rise have been
calling for what has long been labelled the “vax/unvax” study. Public health
officials such as Paul Offit have resisted these calls with claims that a
comparative study of autism risk and other health outcomes in unvaccinated and
vaccinated children would be retrospectively impossible and prospectively
unethical.
Despite opposition from those like Offit, attempts to
launch a formal vax/unvax study have been made for many years. In 2006,
Congresswoman Carolyn Maloney (D, NY) authored what is now called Vaccine
Safety Study Act. Said Maloney to the opponents, “Maybe someone in the medical
establishment will show me why this study is a bad idea, but they haven’t done
it yet.” In 2007, Generation Rescue (one of the Mawson study’s sponsors)
retained a market research firm to undertake a similar survey (it is available
on line and had similar findings but was never published in a scientific
journal).
Less formal surveys focused on whether or not autism was
present in the unvaccinated have also been undertaken in unusual populations,
including the Amish and the patients of alternative health practitioners. Age
of Autism
founder Dan Olmsted investigated autism in the Amish, who vaccinate less
frequently. Autism is rare among the Amish and the only autistic Amish children
we discovered were also vaccinated. (Others reported cases in Amish children
with birth defects, but not “idiopathic autism,” the kind that occurs in
otherwise typical children who are the heart of the current epidemic). The late
Mayer Eisenstein reported in his HomeFirst practice in Chicago that he
delivered more than 15,000 babies at home, and thousands of them were never
vaccinated. Of these unvaccinated children, none had autism.
The link between autism and vaccination became a hot
topic in this year’s presidential election. Democratic candidate Hillary Clinton once
tweeted ““The science is clear: The earth is round, the sky is blue, and
#vaccineswork. Let’s protect all our kids. #GrandmothersKnowBest.”
In contrast, President Donald Trump has long been outspoken about the likely
connection between vaccines and autism. As early as 2007, Trump remarked, “When
I was growing up, autism wasn’t really a factor. And now all of a sudden, it’s
an epidemic. Everybody has their theory, and my theory is the shots. They’re
getting these massive injections at one time. I think it’s the vaccinations.”
MMR vaccine
The MMR vaccine is
generally administered to children around the age of one year, with a second
dose before starting school (i.e. age 4/5). The second dose is a dose to
produce immunity in the small number of persons (2–5%) who fail to develop
measles immunity after the first dose.[3] In the
United States, the vaccine was licensed in 1971 and the second dose was
introduced in 1989.[4] It is
widely used around the world; since introduction of its earliest versions in
the 1970s, over 500 million doses have been used in over 60 countries. The
vaccine is sold by Merck as M-M-R II, GlaxoSmithKline Biologicals as Priorix,
Serum Institute of India
as Tresivac, and Sanofi Pasteur as Trimovax.
It is usually considered a childhood vaccination.
However, it is also recommended for use in some cases of adults with HIV.
Hillary Clinton
Hillary Rodham
Clinton was a director at the Bill,
Hillary & Chelsea Clinton Foundation.
Note: Chelsea V. Clinton
is the vice chair for the Bill, Hillary
& Chelsea Clinton Foundation.
William J. Clinton
is the founder of the Bill, Hillary
& Chelsea Clinton Foundation.
Merck
was a funder for the Bill, Hillary &
Chelsea Clinton Foundation.
Sanofi was a funder for the Bill, Hillary & Chelsea Clinton
Foundation.
Sanofi Pasteur
is a division of Sanofi.
Christopher
A. Viehbacher was a CEO for Sanofi,
and a director at GlaxoSmithKline plc.
James R. Murdoch
was a director at GlaxoSmithKline plc,
a funder for the Bill, Hillary &
Chelsea Clinton Foundation, and is a governing board member for the Indian (India) School of Business.
John D. Coombe
was the CFO for GlaxoSmithKline plc,
and a director at HSBC Holdings plc.
James B. Comey
was a director at the HSBC Holdings plc,
and a director at the Federal Bureau of
Investigation (FBI).
HSBC Holdings
plc was a funder for the Bill,
Hillary & Chelsea Clinton Foundation.
Open
Society Foundations was a funder for the Bill, Hillary & Chelsea Clinton Foundation, the Atlantic Council of the United States
(think tank), the Human Rights Watch,
and the American Civil Liberties Union
(ACLU).
George
Soros is the founder & chairman for the Open Society Foundations, was the chairman for the Foundation to
Promote Open Society, and a benefactor for the Human Rights Watch.
Foundation
to Promote Open Society was a funder for the Human
Rights Watch, the International
Rescue Committee, and the American
Civil Liberties Union (ACLU).
John J. Studzinski
is a director at the Atlantic Council of
the United States (think tank), a director at the Human Rights Watch, the vice chairman for the Blackstone Group, and was a co-head of investment banking for HSBC Holdings plc.
Blackstone Group
was a funder for the Bill, Hillary &
Chelsea Clinton Foundation.
HSBC Holdings
plc was a funder for the Bill,
Hillary & Chelsea Clinton Foundation.
Hillary Rodham
Clinton was a director at the Bill,
Hillary & Chelsea Clinton Foundation.
Chelsea V. Clinton
is the vice chair for the Bill, Hillary
& Chelsea Clinton Foundation.
William J. Clinton
is the founder of the Bill, Hillary
& Chelsea Clinton Foundation.
Merck
was a funder for the Bill, Hillary &
Chelsea Clinton Foundation.
Sanofi
was a funder for the Bill, Hillary &
Chelsea Clinton Foundation.
Sanofi Pasteur
is a division of Sanofi.
James R. Murdoch
was a director at GlaxoSmithKline plc,
a funder for the Bill, Hillary &
Chelsea Clinton Foundation, and is a governing board member for the Indian (India) School of Business.
John D. Coombe
was the CFO for GlaxoSmithKline plc,
and a director at HSBC Holdings plc.
Stuart A. Levey
is a chief legal officer for HSBC
Holdings plc, and was an undersecretary for terrorism, financial
intelligence for the U.S. Department of
the Treasury.
Timothy F.
Geithner was a secretary for the U.S.
Department of the Treasury, and is an overseer, director for the International Rescue Committee.
Andrew Robertson
is an overseer at the International
Rescue Committee, and a director at Autism
Speaks.
Herbert Pardes
is a director at Autism Speaks, and
a director at the Markle Foundation.
Markle
Task Force on National Security in the Information Age is a
national-security project for the Markle
Foundation.
Eric H. Holder Jr.
is a member of the Markle Task Force on
National Security in the Information Age, a partner at Covington & Burling LLP, and Merck was his client.
Covington
& Burling LLP is the lobby firm for Merck, and was the lobby firm for the Ford Foundation.
Merck
was a funder for the Bill, Hillary &
Chelsea Clinton Foundation.
Sanofi
was a funder for the Bill, Hillary &
Chelsea Clinton Foundation.
Sanofi Pasteur
is a division of Sanofi.
James R. Murdoch
was a director at GlaxoSmithKline plc,
a funder for the Bill, Hillary &
Chelsea Clinton Foundation, and is a governing board member for the Indian (India) School of Business.
John D. Coombe
was the CFO for GlaxoSmithKline plc,
and a director at HSBC Holdings plc.
N.R. Narayana Murthy
was a director at HSBC Holdings plc,
and is a trustee at the Ford Foundation.
Anke A. Ehrhardt
was a trustee at the Ford Foundation,
and is a director at the HIV Center for
Clinical and Behavioral Studies.
Ford Foundation
was a funder for the Bill, Hillary &
Chelsea Clinton Foundation, and the International
Rescue Committee.
Andrew Robertson
is an overseer at the International
Rescue Committee, and a director at Autism
Speaks.
Anthony D. Romero
was a director of human rights for the Ford
Foundation, and is an executive director for the American Civil Liberties Union (ACLU).
ACLU Comment on Trump Firing of FBI Director Comey
May 9, 2017
WASHINGTON — American Civil Liberties Union Executive Director Anthony D. Romero issued the following
statement on the firing of FBI Director James
Comey:
No comments:
Post a Comment